ym 09151-2 has been researched along with mosapramine in 1 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (mosapramine) | Trials (mosapramine) | Recent Studies (post-2010) (mosapramine) |
---|---|---|---|---|---|
249 | 6 | 13 | 23 | 1 | 9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mori, H; Sakamoto, H; Shiba, K; Sumiyoshi, T; Suzuki, K; Yamaguchi, N; Yokogawa, K | 1 |
1 other study(ies) available for ym 09151-2 and mosapramine
Article | Year |
---|---|
Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy.
Topics: Animals; Antipsychotic Agents; Benzamides; Benzazepines; Brain; Dibenzazepines; Dopamine D2 Receptor Antagonists; Ketanserin; Male; Pimozide; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Tranquilizing Agents | 1995 |